Research ArticleOriginal Article
Open Access

Dengue fever

Clinical features of 567 consecutive patients admitted to a tertiary care center in Saudi Arabia

Samar Badreddine, Fahmi Al-Dhaheri, Ammar Al-Dabbagh, Abdulrahman Al-Amoudi, Maged Al-Ammari, Nader Elatassi, Haytham Abbas, Rami Magliah, Abdulbasit Malibari and Hani Almoallim
Saudi Medical Journal October 2017, 38 (10) 1025-1033; DOI: https://doi.org/10.15537/smj.2017.10.20965

References

  1. ↵
    1. Bhatt S,
    2. Gething PW,
    3. Brady OJ,
    4. Messina JP,
    5. Farlow AW,
    6. Moyes CL,
    7. et al.
    (2013) The global distribution and burden of dengue. Nature 496:504–507.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Brady OJ,
    2. Gething PW,
    3. Bhatt S,
    4. Messina JP,
    5. Brownstein JS,
    6. Hoen AG,
    7. et al.
    (2012) Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis 6:e1760.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Fakeeh M,
    2. Zaki AM
    (2001) Virologic and serologic surveillance for dengue fever in Jeddah, Saudi Arabia, 1994-1999. Am J Trop Med Hyg 65:764–767.
    OpenUrlAbstract
  4. ↵
    1. Guzman MG,
    2. Halstead SB,
    3. Artsob H,
    4. Buchy P,
    5. Farrar J,
    6. Gubler DJ,
    7. et al.
    (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8(12 Suppl):S7–S16.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Fakeeh M,
    2. Zaki AM
    (2003) Dengue in Jeddah, Saudi Arabia. Dengue Bulletin 27:1994–2002.
    OpenUrl
  6. ↵
    1. Alhaeli A,
    2. Bahkali S,
    3. Ali A,
    4. Househ MS,
    5. El-Metwally AA
    (2016) The epidemiology of Dengue fever in Saudi Arabia: A systematic review. J Infect Public Health 9:117–124.
    OpenUrl
  7. ↵
    1. El-Gilany AH,
    2. Eldeib A,
    3. Hammad S
    (2010) Clinico-epidemiological features of dengue fever in Saudi Arabia. Asian Pac J Trop Med 3:220–223.
    OpenUrlCrossRef
  8. ↵
    1. Zaki A,
    2. Perera D,
    3. Jahan SS,
    4. Cardosa MJ
    (2008) Phylogeny of dengue viruses circulating in Jeddah Saudi Arabia:1994 to 2006. Trop Med Int Health 13:584–592.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Paupy C,
    2. Delatte H,
    3. Bagny L,
    4. Corbel V,
    5. Fontenille D
    (2009) Aedes albopictus, an arbovirus vector: from the darkness to the light. Microbes Infect 11:1177–1185.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Calisher CH,
    2. Karabatsos N,
    3. Dalrymple JM,
    4. Shope RE,
    5. Porterfield JS,
    6. Westaway EG,
    7. et al.
    (1989) Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70(Pt 1):37–43.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Yacoub S,
    2. Mongkolsapaya J,
    3. Screaton G
    (2016) Recent advances in understanding dengue. F1000Res 5:5.
    OpenUrl
  12. ↵
    1. Halstead SB
    (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239:476–481.
    OpenUrlAbstract/FREE Full Text
    1. Kurane I
    (2007) Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis 30:329–340.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Halstead SB
    (2008) Dengue virus-mosquito interactions. Annu Rev Entomol 53:273–291.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Simmons CP,
    2. Farrar JJ,
    3. Nguyen V,
    4. Wills B
    (2012) Dengue. N Engl J Med 366:1423–1432.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Ahmed FU,
    2. Mahmood CB,
    3. Sharma JD,
    4. Hoque SM,
    5. Zaman R,
    6. Hasan MS
    (2001) “Dengue and dengue haemorrhagic fever in children during the 2000 outbreak in Chittagong, Bangladesh,” Dengue Bulletin 25:33–39.
    OpenUrl
    1. Narayanan M,
    2. Aravind MA,
    3. Thilothammal N,
    4. Prema R,
    5. Sargunam CS,
    6. Ramamurty N
    (2002) Dengue fever epidemic in Chennai - a study of clinical profile and outcome. Indian Pediatr 39:1027–1033.
    OpenUrlPubMed
    1. Rigau-Pérez JG,
    2. Clark GG,
    3. Gubler DJ,
    4. Reiter P,
    5. Sanders EJ,
    6. Vorndam AV
    (1998) Dengue and dengue haemorrhagic fever. Lancet 352:971–977.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. World Health Organization
    (2012) Handbook for clinical management of dengue. Handbook for clinical management of dengue (WHO, Geneva).
  20. ↵
    1. Halstead SB,
    2. Nimmannitya S,
    3. Cohen SN
    (1970) Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 42:311–328.
    OpenUrlPubMedWeb of Science
    1. Kouri GP,
    2. Guzmán MG,
    3. Bravo JR
    (1987) Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Trans R Soc Trop Med Hyg 81:821–823.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Lee MS,
    2. Hwang KP,
    3. Chen TC,
    4. Lu PL,
    5. Chen TP
    (2006) Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. J Microbiol Immunol Infect 39:121–129.
    OpenUrlPubMed
  23. ↵
    1. World Health Organization
    (2009) Research SPf, Diseases TiT, Diseases WHODoCoNT, Epidemic WHO, Alert P. Dengue: guidelines for diagnosis, treatment, prevention and control (WHO, Geneva).
  24. ↵
    1. Alzahrani AG,
    2. Al Mazroa MA,
    3. Alrabeah AM,
    4. Ibrahim AM,
    5. Mokdad AH,
    6. Memish ZA
    (2013) Geographical distribution and spatio-temporal patterns of dengue cases in Jeddah Governorate from 2006-2008. Trans R Soc Trop Med Hyg 107:23–29.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Aziz AT,
    2. Al-Shami SA,
    3. Mahyoub JA,
    4. Hatabbi M,
    5. Ahmad AH,
    6. Rawi CS
    (2014) An update on the incidence of dengue gaining strength in Saudi Arabia and current control approaches for its vector mosquito. Parasit Vectors 7:258.
    OpenUrl
  26. ↵
    1. Kholedi AA,
    2. Balubaid O,
    3. Milaat W,
    4. Kabbash IA,
    5. Ibrahim A
    (2012) Factors associated with the spread of dengue fever in Jeddah Governorate, Saudi Arabia. East Mediterr Health J 18:15–23.
    OpenUrlPubMed
  27. ↵
    1. Alwafi OM,
    2. McNabb S,
    3. Memish ZA,
    4. Assiri A,
    5. Alzahrani SH,
    6. Asiri SA,
    7. et al.
    (2013) Dengue Fever in Makkah, Kingdom of Saudi Arabia, 2008-2012. American Journal of Research Communication 1:123–139.
    OpenUrl
  28. ↵
    1. Ayyub M,
    2. Khazindar AM,
    3. Lubbad EH,
    4. Barlas S,
    5. Alfi AY,
    6. Al-Ukayli S
    (2006) Characteristics of dengue fever in a large public hospital, Jeddah, Saudi Arabia. J Ayub Med Coll Abbottabad 18:9–13.
    OpenUrlPubMed
    1. Khan NA,
    2. Azhar EI,
    3. El-Fiky S,
    4. Madani HH,
    5. Abuljadial MA,
    6. Ashshi AM,
    7. et al.
    (2008) Clinical profile and outcome of hospitalized patients during first outbreak of dengue in Makkah, Saudi Arabia. Acta Trop 105:39–44.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    1. Sung V,
    2. O'Brien DP,
    3. Matchett E,
    4. Brown GV,
    5. Torresi J
    (2003) Dengue Fever in travelers returning from southeast Asia. J Travel Med 10:208–213.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Kabra SK,
    2. Jain Y,
    3. Pandey RM,
    4. Madhulika Singhal T,
    5. Tripathi P,
    6. et al.
    (1999) Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 93:294–298.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Lum L,
    2. Ng C,
    3. Khoo E
    (2014) Managing dengue fever in primary care: A practical approach. Malays Fam Physician 9:2–10.
    OpenUrl
  33. ↵
    1. García S,
    2. Morales R,
    3. Hunter RF
    (1995) Dengue fever with thrombocytopenia: studies towards defining vulnerability of bleeding. Bol Asoc Med P R 87:2–7.
    OpenUrlPubMed
  34. ↵
    1. Jyothi P,
    2. Metri BC
    (2015) Correlation of serological markers and platelet count in the diagnosis of Dengue virus infection. Adv Biomed Res 4:26.
    OpenUrl
  35. ↵
    1. Huerre MR,
    2. Lan NT,
    3. Marianneau P,
    4. Hue NB,
    5. Khun H,
    6. Hung NT,
    7. et al.
    (2001) Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch 438:107–115.
    OpenUrlCrossRefPubMedWeb of Science
    1. Lin YL,
    2. Liu CC,
    3. Lei HY,
    4. Yeh TM,
    5. Lin YS,
    6. Chen RM,
    7. et al.
    (2000) Infection of five human liver cell lines by dengue-2 virus. J Med Virol 60:425–431.
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    1. World Health Organization
    (1997) Dengue haemorrhagic fever: diagnosis, treatment, prevention and control (WHO, Geneva).
  38. ↵
    1. Nimmannitya S,
    2. Suntayakom S,
    3. Vaughn D,
    4. Nisalak A,
    5. Green S,
    6. Chansiriwongs V,
    7. et al.
    (1999) Can doctors make an accurate diagnosis of dengue infections at an early stage. Dengue Bulletin, 23.
    1. Mohan B,
    2. Patwari AK,
    3. Anand VK
    (2000) Hepatic dysfunction in childhood dengue infection. J Trop Pediatr 46:40–43.
    OpenUrlCrossRefPubMed
    1. Pancharoen C,
    2. Rungsarannont A,
    3. Thisyakorn U
    (2002) Hepatic dysfunction in dengue patients with various severity. J Med Assoc Thai 85(Suppl1):S298–S301.
    OpenUrlPubMed
  41. ↵
    1. Petdachai W
    (2005) Hepatic Dysfunction in Children with Dengue Shock Syndrome. Dengue Bulletin 29:112–118.
    OpenUrl
  42. ↵
    1. Lanciotti RS,
    2. Calisher CH,
    3. Gubler DJ,
    4. Chang GJ,
    5. Vorndam AV
    (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30:545–551.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Cardosa MJ,
    2. Tio PH,
    3. Nimmannitya S,
    4. Nisalak A,
    5. Innis B
    (1992) IgM capture ELISA for detection of IgM antibodies to dengue virus: comparison of 2 formats using hemagglutinins and cell culture derived antigens. Southeast Asian J Trop Med Public Health 23:726–729.
    OpenUrlPubMed
    1. Gubler D,
    2. Sather G
    (1988) Laboratory diagnosis of dengue and dengue hemorrhagic fever. Simpósio Internacional sobre Febre Amarela e Dengue 15:291–322.
    OpenUrl
  45. ↵
    1. Innis BL,
    2. Nisalak A,
    3. Nimmannitya S,
    4. Kusalerdchariya S,
    5. Chongswasdi V,
    6. Suntayakorn S,
    7. et al.
    (1989) An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 40:418–427.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Khan Assir MZ,
    2. Kamran U,
    3. Ahmad HI,
    4. Bashir S,
    5. Mansoor H,
    6. Anees SB,
    7. et al.
    (2013) Effectiveness of platelet transfusion in dengue Fever: a randomized controlled trial. Transfus Med Hemother 40:362–368.
    OpenUrl
  47. ↵
    1. Low JG,
    2. Sung C,
    3. Wijaya L,
    4. Wei Y,
    5. Rathore AP,
    6. Watanabe S,
    7. et al.
    (2014) Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis 14:706–715.
    OpenUrlCrossRefPubMed
    1. Nguyen NM,
    2. Tran CN,
    3. Phung LK,
    4. Duong KT,
    5. Huynh HA,
    6. Farrar J,
    7. et al.
    (2013) A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 207:1442–1450.
    OpenUrlCrossRefPubMed
    1. Tam DT,
    2. Ngoc TV,
    3. Tien NT,
    4. Kieu NT,
    5. Thuy TT,
    6. Thanh LT,
    7. et al.
    (2012) Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 55:1216–1224.
    OpenUrlCrossRefPubMed
    1. Tricou V,
    2. Minh NN,
    3. Van TP,
    4. Lee SJ,
    5. Farrar J,
    6. Wills B,
    7. et al.
    (2010) A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis 4:e785.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Whitehorn J,
    2. Van Vinh Chau N,
    3. Truong NT,
    4. Tai LT,
    5. Van Hao N,
    6. Hien TT,
    7. et al.
    (2012) Lovastatin for adult patients with dengue: protocol for a randomised controlled trial. Trials 13:203.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Ferguson NM,
    2. Rodríguez-Barraquer I,
    3. Dorigatti I,
    4. Mier-Y-Teran-Romero L,
    5. Laydon DJ,
    6. Cummings DA
    (2016) Benefits and risks of the Sanofi-Pasteur dengue vaccine: modeling optimal deployment. Science 353:1033–1036.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    1. Hadinegoro SR,
    2. Arredondo-García JL,
    3. Capeding MR,
    4. Deseda C,
    5. Chotpitayasunondh T,
    6. Dietze R,
    7. et al.
    (2015) CYD-TDV Dengue Vaccine Working Group. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 373:1195–1206.
    OpenUrlCrossRefPubMed
    1. Shahin W,
    2. Nassar A,
    3. Kalkatttawi M,
    4. Bokhari H
    (2009) Dengue fever in a tertiary hospital in Makkah, Saudi Arabia. Dengue Bulletin 33:34–43.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section